Moreover, the SUMO-C1 group showed a higher expression of co-stimulatory and MHC molecules and lower expression of co-inhibitory molecules (Figures 4E–G), such as CD274, PDCD1, and LAG3, which are now commonly used as immunotherapeutic checkpoints in lung adenocarcinoma. Here, CD274 is linked to lung adenocarcinoma.